Covestor’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
902
-22
-2% -$5.13K 0.13% 107
2026
Q1
$226K Sell
924
-550
-37% -$128K 0.16% 95
2025
Q4
$305K Sell
1,474
-265
-15% -$52.4K 0.16% 100
2025
Q3
$323K Buy
1,739
+259
+18% +$44.4K 0.18% 68
2025
Q2
$226K Sell
1,480
-573
-28% -$88.1K 0.13% 139
2025
Q1
$340K Buy
2,053
+38
+2% +$5.95K 0.23% 43
2024
Q4
$292K Sell
2,015
-132
-6% -$20.5K 0.18% 64
2024
Q3
$348K Sell
2,147
-110
-5% -$17.5K 0.22% 38
2024
Q2
$330K Buy
2,257
+268
+13% +$39.9K 0.21% 47
2024
Q1
$314K Buy
1,989
+660
+50% +$105K 0.2% 43
2023
Q4
$208K Buy
1,329
+26
+2% +$3.99K 0.14% 128
2023
Q3
$203K Sell
1,303
-221
-15% -$36.5K 0.15% 106
2023
Q2
$252K Sell
1,524
-201
-12% -$32.4K 0.19% 67
2023
Q1
$267K Buy
1,725
+109
+7% +$17.6K 0.23% 53
2022
Q4
$286K Sell
1,616
-219
-12% -$37.8K 0.23% 56
2022
Q3
$300K Sell
1,835
-477
-21% -$80.7K 0.26% 37
2022
Q2
$411K Buy
2,312
+494
+27% +$88K 0.33% 28
2022
Q1
$322K Buy
1,818
+602
+50% +$102K 0.21% 53
2021
Q4
$208K Buy
+1,216
New +$199K 0.29% 25

Other funds holding JNJ

Covestor's JNJ Position: Q2 2026 in Review

Covestor reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, selling an estimated $5.13K and leaving 902 shares worth $229K. The position accounts for 0.13% of the portfolio, ranked #107.

Covestor first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $411K in Q2 2022. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Covestor held 902 shares of Johnson & Johnson worth $229K as of Q2 2026.
  • Covestor sold 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 0.13% of Covestor's portfolio in Q2 2026, its #107 holding.
  • Covestor first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Johnson & Johnson position peaked at $411K in Q2 2022.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.